rss
Br J Ophthalmol 2003;87:1432 doi:10.1136/bjo.87.11.1432
  • Mailbox

Thermochemotherapy in hereditary retinoblastoma

  1. R Murthy,
  2. S G Honavar,
  3. M Naik,
  4. V A P Reddy
  1. Ocular Oncology Service, LV Prasad Eye Institute, Hyderabad, India
  1. Correspondence to: Santosh G Honavar MD, Ocular Oncology Service, LV Prasad Eye Institute, LV Prasad Marg, Banjara Hills, Hyderabad 500 034, India; honavarlvpeye.stph.net
  • Accepted 21 April 2003

Schueler and associates describe their experience with thermochemotherapy (TCT) in bilateral retinoblastoma.1 The reported results of transpupillary thermotherapy used in combination with chemotherapy are encouraging, with 86–96% tumour control.2,3 In the current series, however, local recurrence occurred in 38%.

The dosage of carboplatin used in the current series was 10 mg/kg body weight, which is lower than the standard dosage of …

[Full text of this article]

This Article

  1. Extract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

Register for free content


Free sample
 This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Free archive
The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.